211 related articles for article (PubMed ID: 20087267)
1. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
[TBL] [Abstract][Full Text] [Related]
2. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
[TBL] [Abstract][Full Text] [Related]
4. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
Sène D; Ghillani-Dalbin P; Limal N; Thibault V; van Boekel T; Piette JC; Cacoub P
Ann Rheum Dis; 2006 Mar; 65(3):394-7. PubMed ID: 16474032
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
Liu Y; Wang YF; Wang KL; Lv FF
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
[TBL] [Abstract][Full Text] [Related]
8. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands.
ter Borg EJ; Risselada AP; Kelder JC
Semin Arthritis Rheum; 2011 Jun; 40(6):547-51. PubMed ID: 20864144
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
10. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome.
Kim SM; Park E; Lee JH; Lee SH; Kim HR
Rheumatol Int; 2012 Dec; 32(12):3963-7. PubMed ID: 22205381
[TBL] [Abstract][Full Text] [Related]
12. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.
van Noord C; Hooijkaas H; Dufour-van den Goorbergh BC; van Hagen PM; van Daele PL; van de Merwe JP
Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321
[No Abstract] [Full Text] [Related]
14. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.
García-Berrocal B; González C; Pérez M; Navajo JA; Moreta I; Dávila C; González-Buitrago JM
Clin Chim Acta; 2005 Apr; 354(1-2):123-30. PubMed ID: 15748608
[TBL] [Abstract][Full Text] [Related]
15. Image analysis of fibrosis in labial salivary glands of patients with systemic autoimmune diseases. Close correlation of lobular fibrosis to seropositive rheumatoid arthritis and increased anti-CCP and RF titres in the serum.
Katona K; Farkas N; Kneif M; SütŐ G; Berki T; Balatonyi B; Tornóczky T
Pathology; 2018 Jun; 50(4):418-425. PubMed ID: 29735168
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
Haga HJ; Andersen DT; Peen E
Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
[TBL] [Abstract][Full Text] [Related]
17. Anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren's syndrome.
Tobón GJ; Correa PA; Anaya JM
Ann Rheum Dis; 2005 May; 64(5):791-2. PubMed ID: 15834066
[No Abstract] [Full Text] [Related]
18. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S
J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395
[TBL] [Abstract][Full Text] [Related]
20. The active immunological profile in patients with primary Sjögren's syndrome is restricted to typically encountered autoantibodies.
Capaldo C; Carvajal Alegria G; Cornec D; Jousse-Joulin S; Devauchelle-Pensec V; Renaudineau Y
Clin Exp Rheumatol; 2016; 34(4):722. PubMed ID: 27191916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
